iBio (IBIO) is scheduled to report Q4 earnings on September 4, 2026. Analysts estimate EPS of $-0.06 and quarterly revenue of $66.67K.
In the most recent quarter (Q3), iBio reported EPS of $-0.07, missing estimates of $-0.06 by 0.17%. Revenue came in at $0, missing the estimate of $36.00K by 1.00%.
iBio has missed EPS estimates in 6 consecutive quarters.
Over the last 4 quarters, iBio has averaged an EPS surprise of 0.30% and a revenue surprise of 0.95%.
Earnings Date
Sep 4
EPS Estimate
$-0.060
Quarterly Revenue Estimate
$66.67K
Annual Revenue
$300.00K
as of Mar 31
Analyze the earnings history of iBio using advanced sorting and filters.
The chart below shows iBio's reported EPS compared to analyst estimates over recent quarters.
The chart below shows iBio's reported revenue compared to analyst estimates over recent quarters.
iBio (IBIO) is scheduled to report earnings on September 4, 2026. The last reported earnings were for reported on May 12, 2026 for Q3.
The Actual EPS was $-0.07, which missed the estimate of $-0.06.
The Actual Revenue was $0, which missed the estimate of $36.00K.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | May 12, 2026 | $-0.07 | $-0.06 | -16.7 % |
| Q2 | Feb 10, 2026 | $-0.09 | $-0.07 | -28.6 % |
| Q1 | Nov 12, 2025 | $-0.11 | $-0.07 | -57.1 % |
| Q4 | Sep 5, 2025 | $-0.32 | $-0.25 | 15.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | May 12, 2026 | $0 | $36.00K | -100.0 % |
| Q2 | Feb 10, 2026 | $0 | $60.00K | -100.0 % |
| Q1 | Nov 12, 2025 | $100.00K | $55.00K | 81.8 % |
| Q4 | Sep 5, 2025 | $200.00K | $100.00K | 100.0 % |